RCM TECHNOLOGIES, INC.
No enriched coverage for $RCMT in the last 7 days.
No SEC Form 4 filings for $RCMT in the last 30 days.
See all $RCMT insider activity →Zacks upgraded five stocks to Strong Buy: RCM Technologies (RCMT), Healthcare Services Group (HCSG), Bloomin' Brands (BLMN), Argan (AGX), and Globus Medical (GMED). Their earnings estimates rose 13.3%, 12.9%, 10.1%, 6.7%, and 5.3% respectively in 60 days.
MILLER KEVIN D (CFO) sold 22,501 shares of RCM TECHNOLOGIES, INC. (RCMT) at an average of $42.17 ($42.00–$42.19, $0.95M total) across 2 trades over 2026-08-28 to 2026-08-31 under a Rule 10b5-1 trading plan.
RCM TECHNOLOGIES, INC. (RCMT) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers On August 13, 2026, the Compensation Committee (the “Committee”) of the Board of Directors of RCM Technologies, Inc. (the “C
Recent RCMT coverage spans insider activity, financial news and earnings.
Potential short‑term interest from momentum traders.
Minor dilution of insider confidence; likely negligible price impact.
Compensation grants may dilute existing shareholders and signal confidence in management performance targets.
Higher guidance could support the stock.
The insider sale may signal modest negative sentiment, potentially exerting slight downward pressure on the stock.
AlphAI scores every news story that mentions RCMT with an AI model for sentiment and relevance, and aggregates insider trades from RCM TECHNOLOGIES, INC.'s SEC EDGAR Form 4 filings. Figures refresh continuously.
Zacks upgraded five stocks to Strong Buy: RCM Technologies (RCMT), Healthcare Services Group (HCSG), Bloomin' Brands (BLMN), Argan (AGX), and Globus Medical (GMED). Their earnings estimates rose 13.3%, 12.9%, 10.1%, 6.7%, and 5.3% respectively in 60 days.
1 min readMILLER KEVIN D (CFO) sold 22,501 shares of RCM TECHNOLOGIES, INC. (RCMT) at an average of $42.17 ($42.00–$42.19, $0.95M total) across 2 trades over 2026-08-28 to 2026-08-31 under a Rule 10b5-1 trading plan.
1 min readRCM TECHNOLOGIES, INC. (RCMT) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers On August 13, 2026, the Compensation Committee (the “Committee”) of the Board of Directors of RCM Technologies, Inc. (the “C
1 min readZacks.com highlighted four companies with strong net profit margins: Nutex Health (NUTX), RCM Technologies (RCMT), Remitly Global (RELY), and Belden (BDC). Each company's 2026 earnings estimates were revised upward, with NUTX up 32.5%, RCMT up 13.3%, RELY up 13.8%, and BDC up 5.7%. All companies recently beat earnings estimates.
2 min readSaks Michael (Division President, HC Srvs.) sold 10,000 shares of RCM TECHNOLOGIES, INC. (RCMT) at an average of $41.07 ($40.78–$41.24, $0.41M total) across 2 trades on 2026-08-18.
1 min readMILLER KEVIN D (CFO) sold 94,413 shares of RCM TECHNOLOGIES, INC. (RCMT) at an average of $36.91 ($34.02–$42.00, $3.48M total) across 6 trades over 2026-08-14 to 2026-08-18 under a Rule 10b5-1 trading plan.
2 min readVizi Bradley (Executive Chairman & President) sold 100,000 shares of RCM TECHNOLOGIES, INC. (RCMT) at an average of $37.89 ($35.02–$40.06, $3.79M total) across 3 trades over 2026-08-14 to 2026-08-17 under a Rule 10b5-1 trading plan.
2 min readRCM Technologies (RCMT) reported Q2 adjusted EPS of $0.82, above the Zacks Consensus Estimate of $0.54, versus $0.69 a year earlier. Revenue rose to $93.82 million, up from $78.17 million and above consensus by 16.3%. The article cites a Zacks Rank #3 (Hold) and notes next-quarter consensus EPS of $0.57.
5 min readMichael Saks, Division President, HC Services at RCM Technologies Inc (RCMT), sold 1,208 shares of the company on May 4, 2026, reducing his holdings to 89,267 shares. This transaction follows a pattern of insider selling over the past year, with no insider buys recorded. The stock is currently trading at $32.50, and GuruFocus classifies it as modestly overvalued with a price-to-GF-Value ratio of 1.21.
3 min readRCM Technologies (NASDAQ:RCMT) CFO Kevin Miller recently sold 4,734 shares of the company's stock for $151,488. The transaction, executed under a pre-arranged plan, reduced his stake by 1.07% to 439,066 shares. Analysts currently have an average "Buy" rating on RCMT with a price target of $36.00, while institutional investors own about 43.2% of the stock.
2 min read
